<SEC-DOCUMENT>0001062993-24-020549.txt : 20241212
<SEC-HEADER>0001062993-24-020549.hdr.sgml : 20241212
<ACCEPTANCE-DATETIME>20241212171318
ACCESSION NUMBER:		0001062993-24-020549
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20241212
DATE AS OF CHANGE:		20241212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Flora Growth Corp.
		CENTRAL INDEX KEY:			0001790169
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-274204
		FILM NUMBER:		241545907

	BUSINESS ADDRESS:	
		STREET 1:		3230 W. COMMERCIAL BOULEVARD
		STREET 2:		SUITE 180
		CITY:			FORT LAUDERDALE
		STATE:			FL
		ZIP:			33309
		BUSINESS PHONE:		416-861-2267

	MAIL ADDRESS:	
		STREET 1:		3230 W. COMMERCIAL BOULEVARD
		STREET 2:		SUITE 180
		CITY:			FORT LAUDERDALE
		STATE:			FL
		ZIP:			33309
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>form424b3.htm
<DESCRIPTION>FORM 424B3
<TEXT>
<html>

<head>
    <title>Flora Growth Corp.: Form 424B3 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="margin-bottom: 0pt; text-align: right;">Filed pursuant to Rule 424(b)(3)<br>Registration No. 333-274204</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><b>SUPPLEMENT NO 1. DATED December 12, 2024 </b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><b>TO PROSPECTUS SUPPLEMENT DATED April 26, 2024 </b></p>
    <p style="margin-top: 0pt; text-align: justify;">(To Prospectus Dated September 6, 2023)</p>
    <p style="text-align: center;"><img src="form424b3x001.jpg" style="width: 131px;" height="154"></p>
    <p style="text-align: center;"><b>Flora Growth Corp.</b></p>
    <p style="text-indent: 24.5pt; text-align: justify;">This Supplement No. 1 to Prospectus Supplement (this "Supplement") supplements and amends the Prospectus Supplement dated April 26, 2024 (the "Prospectus Supplement"). This Supplement should be read in conjunction with the Prospectus Supplement and the accompanying Prospectus dated September 6, 2024 (the "Prospectus"). This Supplement is qualified by reference to the Prospectus Supplement, except to the extent that the information presented herein supersedes the information contained in the Prospectus Supplement.</p>
    <p style="text-indent: 24.5pt; text-align: justify;">On April 26, 2024, we entered into an At-The-Market Issuances Sales Agreement (the "Sales Agreement") with Aegis Capital Corp., as sales agent (the "Agent"), relating to common shares offered by the Prospectus Supplement and the accompanying Prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell common shares having an aggregate offering price of up to $3,794,000 from time to time through the Agent pursuant to at-the-market transactions (the "ATM"). As of the date of this Supplement, we have sold no common shares pursuant to the Sales Agreement.</p>
    <p style="text-indent: 24.5pt; text-align: justify;">The purpose of this Supplement is to terminate the ATM and the continuous offering by us under the Prospectus Supplement, effective on December 12, 2024. The Sales Agreement was terminated effective December 12, 2024.</p>
    <p style="text-align: justify;"><b>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense. </b></p>
    <hr style="border-top-style: none; border-bottom: 0.75pt solid #000000;">
    <p style="text-align: center;"><b>The date of this Supplement No. 1 to Prospectus Supplement is December 12, 2024.</b></p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>form424b3x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form424b3x001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" ": ((# 2(  A$! Q$!_\0
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<  (P  !BI*]:C'EI11RRU;"BBBM20HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
